Your browser doesn't support javascript.
loading
Letter to the Editor: Statins as potential confounding factors to investigate the association between the use of GLP-1 receptor agonists and risk of HCC.
Li, Zheng; Zhang, Yi; Li, Ying; Lan, Jie; Hu, Yuzhu; Yu, Jiayun; Meng, Qianqian; Zou, Bingwen.
Afiliação
  • Li Z; Department of Radiation Oncology, Division of Thoracic Tumor Multimodality Treatment and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang Y; Department of Radiation Oncology, Division of Thoracic Tumor Multimodality Treatment and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Li Y; Department of Radiation Oncology, Division of Thoracic Tumor Multimodality Treatment and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Lan J; Department of Radiation Oncology, Division of Thoracic Tumor Multimodality Treatment and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Hu Y; Department of Radiation Oncology, Division of Thoracic Tumor Multimodality Treatment and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Yu J; Department of Radiation Oncology, Division of Thoracic Tumor Multimodality Treatment and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Meng Q; Department of Radiotherapy Physics and Technology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Zou B; Department of Radiation Oncology, Division of Thoracic Tumor Multimodality Treatment and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Hepatology ; 79(6): E169-E170, 2024 Jun 01.
Article em En | MEDLINE | ID: mdl-38441957

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Inibidores de Hidroximetilglutaril-CoA Redutases / Receptor do Peptídeo Semelhante ao Glucagon 1 / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Inibidores de Hidroximetilglutaril-CoA Redutases / Receptor do Peptídeo Semelhante ao Glucagon 1 / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos